Industry: Health Care – Biotechnology: Pharmaceutical Preparations
Stock Symbol: TAOX – NASDAQ
Animal Usage: Animal Testing
The company, formerly operating as the biopharmaceutical firm Synaptogenix, Inc., is included on the Cruelty Free Investing use of animals list due to its historical involvement in animal testing. As part of its drug development activities, the company conducted pre-clinical studies on animals, including mice and rats, to evaluate the safety and effectiveness of its lead drug candidate, Bryostatin-1, for neurodegenerative diseases. Although the company has since shifted its focus to cryptocurrency and AI, this legacy research and development activity constitutes animal exploitation through testing.
Supporting Evidence:
The company confirms in the following report that they exploit animals for product testing.
“The new synaptic connections formed from the damaged neurons revitalized by PKC ε in rats can be demonstrated in various behavioral models for the animals that are used to measure memory functions.” (Page 13) Read the full document
TAO Synergies Inc. owns and operates an AI token. The company executes a cryptocurrency treasury strategy centered on the acquisition and staking of the TAO token, the native utility token of the Bittensor network. TAO Synergies Inc. was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. The company was incorporated in 2012 and is headquartered in New York, New York.
Company Website: https://www.taosynergies.com